Table 3.
NTRK IHC and results of RNA-sequencing
Scoring group | Totally negative | Focal, weak | Focal, moderate/strong | Widespread, weak | Widespread, moderate/strong |
---|---|---|---|---|---|
NTRK TMA N (%) | 878 (93.4%) | 19 (2.0%) | 17 (1.8%) | 17 (1.8%) | 9 (1.0%) |
Mean/median H-score (range) | 0 | 24.2/20 (10–40) | 58.5/50 (15–120) | 94.7/90 (50–150) | 223.3/220 (140–300) |
RNA NGS number analyzed | 62 | 1 | 17 | 17 | 9 |
--Fusions |
ALK: 1 RET: 1 ROS1: 3 MET ex. 14 skip: 1 Negative: 54 Failed: 2 |
Negative: 1 |
FGFR3: 1 Negative: 15 Failed: 1 |
Negative: 16 Failed: 1 |
MYB: 1 Negative: 8 |
No NTRK fusions were found with NGS. The two positive salivary gland carcinomas had strong and widespread positive IHC, and one had a MYB-NFIB fusion and the other a ERBB2 mutation
Met ex 14 skip = Met exon 14 skipping
CNV, copy number variation